On Tuesday, life sciences company LabCorp announced a new technology platform to help streamline the clinical trial and drug development process. The platform was designed for LabCorp’s drug ...
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced new capabilities ...
Advancements in Technology and Patient Access Deliver Better Clinical Trial Access, Quality, and Experiences BURLINGTON, N.C.--(BUSINESS WIRE)-- LabCorp (NYSE: LH), a leading global life sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results